4,486
Views
48
CrossRef citations to date
0
Altmetric
Immunology

Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation

, , &
Pages 983-988 | Received 08 Oct 2018, Accepted 24 Oct 2018, Published online: 20 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Leila Achour, Chema Drira, Mohamed Zied Sboui, Ikram Fazaa, Mohamed Ali Soussi, Senda Hammami, Tarek Ben Othman & Myriam Razgallah Khrouf. (2023) Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of Tunisia. Journal of Market Access & Health Policy 11:1.
Read now
Xingyue Huang, Namita Joshi, Linlin Luo, Nisreen Shamseddine & Xin Gao. (2021) Continuation of Systemic Treatments and Outcomes for Patients with Chronic Graft-Versus-Host Disease in the USA. Immunotherapy 13:5, pages 387-395.
Read now

Articles from other publishers (46)

Richard T. Maziarz, Usama Gergis, Marie Louise Edwards, Yan Song, Qing Liu, Annika Anderson, James Signorovitch, Rocio Manghani, Ronit Simantov, Heayoung Shin & Smitha Sivaraman. (2024) Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective. Blood Advances 8:5, pages 1200-1208.
Crossref
Jean S. Edward, Mary Kay Rayens, Laurie E. McLouth, Lori P. Eisele, Joan Scales, Lovoria B. Williams & Gerhard Hildebrandt. (2024) A dyadic analysis of financial toxicity and health‐related quality of life among bone marrow transplant patients and their caregivers. Psycho-Oncology 33:2.
Crossref
Ruihao Huang, Ting Chen, Sanbin Wang, Jishi Wang, Yi Su, Jing Liu, Yanqi Zhang, Xiangyu Ma, Qin Wen, Peiyan Kong, Cheng Zhang, Lei Gao, Jiang F. Zhong, Li Gao & Xi Zhang. (2024) Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant. JAMA Oncology 10:2, pages 220.
Crossref
Udo Holtick, Nadia Quignot, Raissa Kapso-Kapnang, Dawn Reichenbach, Maebh Kelly, Anita Burrell, Xiang Zhang & Kris Thiruvillakkat. (2024) Clinical and Economic Burden Associated With Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation in Germany. Transplantation Proceedings 56:1, pages 191-200.
Crossref
Navneet S. Majhail, Beckley Miller, Rebecca Dean, Rocio Manghani, Heayoung Shin, Smitha Sivaraman & Richard T. Maziarz. (2023) Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial. Transplantation and Cellular Therapy 29:12, pages 749.e1-749.e5.
Crossref
Ziheng Xu, Jaebok Choi, Matthew Cooper, Jeffrey King, Mark A. Fiala, Jingxia Liu, Iskra Pusic, Rizwan Romee, Amanda Cashen, Meagan A. Jacoby, Keith Stockerl-Goldstein, Camille Abboud, Ravi Vij, Geoffrey Uy, Peter Westervelt, Matthew J. Walter, John F. DiPersio & Mark A. Schroeder. (2023) Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy 29:11, pages 699.e1-699.e9.
Crossref
竜太郎 松垣, 誠 大谷, 悠子 峰, 覚 佐伯, 清秀 伏見 & 晋哉 松田. (2023) Pre-transplant Rehabilitation to Decrease the Post-transplant Length of Stay for Hematological Malignancy Patients Undergoing Allo-HSCT二次出版:同種造血幹細胞移植を受けた血液腫瘍患者に対する移植前リハビリテーションと移植後在院日数との関係. The Japanese Journal of Rehabilitation Medicine 60:9, pages 810-818.
Crossref
Monzr M. Al Malki, Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra, Hannah Choe, Elizabeth Hexner, Amelia Langston, Sunil Abhyankar, Doris M. Ponce, Zachariah DeFilipp, Carrie L. Kitko, Kehinde Adekola, Ran Reshef, Francis Ayuk, Alexandra Capellini, Chantiya Chanswangphuwana, Matthias Eder, Gilbert Eng, Isha Gandhi, Stephan Grupp, Sigrun Gleich, Ernst Holler, Nora Rebeka Javorniczky, Stelios Kasikis, Steven Kowalyk, George Morales, Umut Özbek, Wolf Rösler, Nikolaos Spyrou, Gregory Yanik, Rachel Young, Yi-Bin Chen, Ryotaro Nakamura, James L. M. Ferrara & John E. Levine. (2023) Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Blood Advances 7:17, pages 5189-5198.
Crossref
Cory Pettit, John Trinidad, Catherine Chung, Andrew Patterson & Benjamin H. Kaffenberger. (2023) Hospital triage and skin disease: hospital outcomes are differentially associated with cutaneous morphology. International Journal of Dermatology 62:8, pages 1034-1039.
Crossref
Florent Malard, Michael Loschi, Anne Huynh, Thomas Cluzeau, Sarah Guenounou, Faezeh Legrand, Leonardo Magro, Corentin Orvain, Amandine Charbonnier, Marta Panz-Klapuch, Deborah Desmier, Jean-Baptiste Mear, Jérôme Cornillon, Christine Robin, Etienne Daguindau, Karin Bilger, Maria J.G.T. Vehreschild, Patrice Chevallier, Hélène Labussière-Wallet, Clémence Mediavilla, Marie-Anne Couturier, Claude-Eric Bulabois, Vincent Camus, Sylvain Chantepie, Patrice Ceballos, Béatrice Gaugler, Ernst Holler, Joël Doré, Emmanuel Prestat, Cyrielle Gasc, Emilie Plantamura & Mohamad Mohty. (2023) Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial. eClinicalMedicine 62, pages 102111.
Crossref
Catherine Lynn T. Silao, Zarina Abdul Latiff, Petros Kountouris & Bin Alwi Zilfalil. (2023) Editorial: Insights in thalassemia: from genomics to clinical practice. Frontiers in Pediatrics 11.
Crossref
Moises Garcia-Rosa, Allistair Abraham, Alice Bertaina, Senthil Velan Bhoopalan, Carmem Bonfim, Sandra Cohen, Amy DeZern, Chrystal Louis, Joseph Oved, Mara Pavel-Dinu, Duncan Purtill, Annalisa Ruggeri, Athena Russell, Akshay Sharma, Robert Wynn, Jaap Jan Boelens & Susan Prockop. (2023) International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant. Cytotherapy 25:6, pages 578-589.
Crossref
Ivan Pasic, Annie H. Ren, Ram Vasudevan Nampoothiri, Ioannis Prassas, Jeffrey H. Lipton, Jonas Mattsson, Eleftherios P. Diamandis & Fotios V. Michelis. (2023) Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation. Clinical Chemistry and Laboratory Medicine (CCLM) 61:6, pages 1005-1014.
Crossref
Jean S. Edward, Laurie E. McLouth, Mary Kay Rayens, Lori P. Eisele, Tani S. Davis & Gerhard Hildebrandt. (2023) Coverage and Cost-of-Care Links: Addressing Financial Toxicity Among Patients With Hematologic Cancer and Their Caregivers . JCO Oncology Practice 19:5, pages e696-e705.
Crossref
David Michonneau, Nadia Quignot, Heng Jiang, Dawn Reichenbach, Maebh Kelly, Anita Burrell, Xiang Zhang, Kris Thiruvillakkat & Mohamad Mohty. (2023) Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France. Bone Marrow Transplantation 58:5, pages 514-525.
Crossref
Meng-Zhu Shen, Shen-Da Hong, Rui Lou, Rui-Ze Chen, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu, Xiao-Jun Huang & Xiao-Dong Mo. (2022) A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation. Experimental Hematology & Oncology 11:1.
Crossref
Allen Cheng-Wei Li, Chen Dong, Soon-Tzeh Tay, Ashwin Ananthakrishnan & Kevin Sheng-Kai Ma. (2022) Vedolizumab for acute gastrointestinal graft-versus-host disease: A systematic review and meta-analysis. Frontiers in Immunology 13.
Crossref
Leonardo Javier Arcuri, Cinthya Corrêa da Silva, Lidiane Soares Sodre da Costa, Mirele Vanesca Ferreira dos Santos, Ancelmo Honorato Ferraz de Sousa, Cristina Vogel, Angelo Maeda Rojas, Helena Lumi Fukumoto, Marci Pietrocola, Paula Oliveira de Souza, Silvia Regina Morgado, Tânia Michele Barreto Waisbeck & Nelson Hamerschlak. (2022) Costs of matched-sibling, unrelated, and haploidentical hematopoietic cell transplantation and risk factors for greater financial burden — a Brazilian FACT-accredited single-center analysis. Annals of Hematology 101:11, pages 2507-2513.
Crossref
Elizabeth J. Bell, Jingbo Yu, Valkal Bhatt, Scott H. Bunner, Lincy S. Lal, John Galvin & Daniel Weisdorf. (2022) Healthcare Resource Utilization and Costs of Steroid-Associated Complications in Patients With Graft-Versus-Host Disease. Transplantation and Cellular Therapy 28:10, pages 707.e1-707.e7.
Crossref
Shuang Fan, Wen-Xuan Huo, Yang Yang, Meng-Zhu Shen & Xiao-Dong Mo. (2022) Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis. Frontiers in Immunology 13.
Crossref
T. S. Shubina, I. V. Zakharov, S. G. Podlipaeva, D. S. Abramov & D. N. Balashov. (2022) The role of endoscopy in the diagnosis of acute intestinal “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation. Pediatric Hematology/Oncology and Immunopathology 21:2, pages 48-53.
Crossref
Lorenzo Sabatelli, Mikko Keränen, Elisabet Viayna, Montserrat Roset, Nuria Lara, Daniel Thunström, Minja Pfeiffer, Malin Nicklasson & Maija Itälä-Remes. (2022) Burden of hospitalizations and outpatient visits associated with moderate and severe acute graft-versus-host disease in Finland and Sweden: a real-world data study. Supportive Care in Cancer 30:6, pages 5125-5135.
Crossref
Nikolett Lupsa, Ákos Szegedi, András Gézsi, Zoltán Vuncs, Tamás Masszi, Gábor Mikala, Péter Reményi, Sara Deola, Arun Prasath Lakshmanan, Annalisa Terranegra, Edit I. Buzás & Zoltán Pós. (2022) Decreased Plasma Level of Cytokeratin 20 (KRT20) Is Indicative of the Emergence and Severity of Acute GvHD Irrespective to the Type of Organ Involvement. Biomedicines 10:3, pages 519.
Crossref
Ilknur Kozanoglu & Funda Pepedil-Tanrikulu. (2022) Functions of the endothelium and its role in hematopoietic cell transplantation. Transfusion and Apheresis Science 61:1, pages 103368.
Crossref
Dandan Lin, Bo Hu, Pengfei Li, Ye Zhao, Yang Xu & Depei Wu. (2021) Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Experimental Hematology & Oncology 10:1.
Crossref
Machaon Bonafede, Elias Anaissie, Kristin Evans & Robbin Itzler. (2021) Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis. BMC Health Services Research 21:1.
Crossref
Nosha Farhadfar, Helen L. Leather, Shu Wang, Nathan Burton, Vivian IrizarryGatell, Robbin Itzler, Ramzi G. Salloum & John R. Wingard. (2021) Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes. Transplantation and Cellular Therapy 27:12, pages 1007.e1-1007.e8.
Crossref
Arjun Patel, Guru Subramanian Guru Murthy, Mehdi Hamadani, Aniko Szabo & Jennifer M. Knight. (2021) The impact of beta-blocker use at the time of hematopoietic cell transplantation on the development of acute and chronic graft-versus-host disease. Hematology/Oncology and Stem Cell Therapy.
Crossref
Deborah S. Hooker, Kristin Grabe-Heyne, Christof Henne, Peter Bader, Mondher Toumi & Stephen J. Furniss. (2021) Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease. Clinical Drug Investigation 41:11, pages 929-939.
Crossref
Sara Alonso-Álvarez, Enrique Colado, Marco A. Moro-García & Rebeca Alonso-Arias. (2021) Cytomegalovirus in Haematological Tumours. Frontiers in Immunology 12.
Crossref
Jean El Cheikh, Rola Cheaito, Sarah S. Abdul-Nabi, Mohamad Ali Cheaito, Afif Jean Mufarrij, Hani Tamim, Maha Makki & Imad El Majzoub. (2021) Predictors of a short hospitalization in bone marrow transplantation patients presenting to the emergency department. The American Journal of Emergency Medicine 45, pages 117-123.
Crossref
Michael GrabnerEric StratiKaren SandmanAnna Forsythe. (2021) Economic burden of acute steroid-refractory graft-versus-host disease in commercially insured pediatric patients. Journal of Managed Care & Specialty Pharmacy 27:5, pages 607-614.
Crossref
M. F. Beckman, D. S. Morton, F. Bahrani Mougeot & J-L. C. Mougeot. (2020) Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures. Supportive Care in Cancer 29:4, pages 1765-1779.
Crossref
Amandeep Godara, Nauman S. Siddiqui, Satish Munigala, Rishi Dhawan, Ankit J. Kansagra, Aaron P. Rapoport, Jean A. Yared & Saurabh Dahiya. (2021) Length of Stay and Hospital Costs for Patients Undergoing Allogeneic Stem-Cell Transplantation. JCO Oncology Practice 17:3, pages e355-e368.
Crossref
Ryutaro Matsugaki, Makoto Ohtani, Yuko Mine, Satoru Saeki, Kiyohide Fushimi & Shinya Matsuda. (2021) Pre-transplant Rehabilitation to Decrease the Post-transplant Length of Stay for Hematological Malignancy Patients Undergoing Allo-HSCT. Progress in Rehabilitation Medicine 6:0, pages n/a.
Crossref
Kumutnart Chanprapaph, Kanchana Leerunyakul, Pimjai Niparuck & Suthinee Rutnin. (2020) A clinical and histological comparison between acute cutaneous graft‐versus‐host disease and other maculopapular eruptions following hematopoietic stem cell transplantation: a retrospective cohort. International Journal of Dermatology 60:1, pages 60-69.
Crossref
Susan Schubach Slater. 2021. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook 423 452 .
Derya Sağraç, Hatice Burcu Şişli, Selinay Şenkal, Taha Bartu Hayal, Fikrettin Şahin & Ayşegül Doğan. 2021. Cell Biology and Translational Medicine, Volume 14. Cell Biology and Translational Medicine, Volume 14 45 64 .
Poommetee Ketson & Patiwet Wuttisarnwattana. (2020) White Pulp Segmentation Algorithm for Mouse Spleen Cryo-imaging Data Using U-Net. White Pulp Segmentation Algorithm for Mouse Spleen Cryo-imaging Data Using U-Net.
Jingbo Yu, Lincy Lal, Amy Anderson, Mary DuCharme, Shreekant Parasuraman & Daniel Weisdorf. (2020) Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation. Supportive Care in Cancer 28:11, pages 5491-5499.
Crossref
Maryanne Covington, Xin He, Monika Scuron, Jun Li, Robert Collins, Ashish Juvekar, Niu Shin, Margaret Favata, Karen Gallagher, Sarala Sarah, Chu-biao Xue, Michael Peel, Krista Burke, Julian Oliver, Brittany Fay, Wenqing Yao, Taisheng Huang, Peggy Scherle, Sharon Diamond, Robert Newton, Yan Zhang & Paul Smith. (2020) Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases. European Journal of Pharmacology 885, pages 173505.
Crossref
Gerhard C. Hildebrandt & Nelson Chao. (2020) Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation. British Journal of Haematology 190:4, pages 508-519.
Crossref
Mark A. SchroederH. Jean KhouryMadan JagasiaHaris Ali, Gary J. SchillerKarl StaserJaebok Choi, Leah GehrsMichael C. ArbushitesYing YanPeter LangmuirNithya SrinivasMichael PrattaMiguel-Angel PeralesYi-Bin Chen, Gabrielle Meyers & John F. DiPersio. (2020) A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease. Blood Advances 4:8, pages 1656-1669.
Crossref
Jingbo Yu, Jennifer T. Judy, Shreekant Parasuraman, Meenal Sinha & Daniel Weisdorf. (2020) Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients with Acute Graft-versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, following Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 26:3, pages 600-605.
Crossref
Angela Ricci, Zhezhen Jin, Larisa Broglie, Monica Bhatia, Diane George, James H. Garvin, Matthew Hall & Prakash Satwani. (2019) Healthcare utilization and financial impact of acute-graft-versus host disease among children undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation 55:2, pages 384-392.
Crossref
Miriam López-Parra, Eva M. Villarón & Fermín Sánchez-Guijo. 2019. Stem Cell Transplantation for Autoimmune Diseases and Inflammation. Stem Cell Transplantation for Autoimmune Diseases and Inflammation 77 88 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.